Time filter

Source Type

Wang W.-Z.,Guangdong Province Key Laboratory of Pharmaceutical Bioactive Substances | Wang W.-Z.,Guangdong Pharmaceutical University | Pu Q.-H.,Guangdong Province Key Laboratory of Pharmaceutical Bioactive Substances | Pu Q.-H.,Guangdong Pharmaceutical University | And 11 more authors.
Leukemia Research

BCR-ABL tyrosine kinase inhibitor imatinib fails to eradicate leukemia stem cells (LSCs), the underlying mechanisms maintaining CML LSCs remain poorly understood. Here, we showed that transient inhibition of miR-21 by antagomiR-21 markedly increased imatinib-induced apoptosis in CML, but not normal CD34+ stem/progenitor cells. Furthermore, PI3K inhibitors also significantly sensitized CML CD34+ cells to imatinib-induced apoptosis. MiR-21 or PI3K inhibitor in combination with imatinib treatment significantly decreased AKT phosphorylation and c-Myc expression than either agent did alone, but did not affect Bim and Bcl-6 expresssion. These findings indicate that miR-21 is required for maintaining the imatinib-resistant phenotype of CML CD34+ cells through PI3K/AKT signaling pathway, thus providing the basis for a promising therapeutic approach to eliminate CML LSCs. © 2015 Elsevier Ltd. Source

Jin X.-B.,Guangdong Pharmaceutical University | Jin X.-B.,Guangdong Province Key Laboratory of Pharmaceutical Bioactive Substances | Wang Y.-J.,Guangdong Pharmaceutical University | Wang Y.-J.,Guangdong Province Key Laboratory of Pharmaceutical Bioactive Substances | And 12 more authors.
Asian Pacific Journal of Cancer Prevention

Conventional chemotherapy against hepatocellular carcinoma typically causes various side effects. Our previous study showed that cecropin of Musca domestica can induce apoptosis in human hepatocellular carcinoma BEL-7402 cells in vitro. However, whether cecropin inhibits BEL-7402 cell in vivo and the question of possible side effects remained undentified. The present study confirmed tumor-inhibitory effects of cecropin in vivo, and furthermore strongly suggested that cecropin cytotoxicity in BEL-7402 cells in vivo may be mainly derived from its pro-apoptotic action. Specifically, we found that cecropin exerted no obvious side effects in tumor-bearing mice as it had no significant hematoxicity as well as visceral toxicity. Therefore, cecropin may be a potential candidate for further investigation as an antitumor agent against hepatocellular carcinoma. Source

Discover hidden collaborations